Raymond James Financial Services Advisors Inc. lifted its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 5.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 195,058 shares of the company’s stock after purchasing an additional 9,524 shares during the period. Raymond James Financial Services Advisors Inc. owned about 0.16% of Clorox worth $30,866,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Dark Forest Capital Management LP purchased a new stake in shares of Clorox during the fourth quarter worth about $28,000. OLD Mission Capital LLC purchased a new stake in Clorox during the 4th quarter valued at about $29,000. Delta Asset Management LLC TN purchased a new stake in Clorox during the 4th quarter valued at about $31,000. Financial Avengers Inc. grew its stake in Clorox by 86.0% during the 4th quarter. Financial Avengers Inc. now owns 225 shares of the company’s stock valued at $32,000 after acquiring an additional 104 shares in the last quarter. Finally, Koesten Hirschmann & Crabtree INC. purchased a new stake in Clorox during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own 79.37% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on CLX. StockNews.com began coverage on shares of Clorox in a research note on Thursday, May 18th. They set a “hold” rating for the company. Royal Bank of Canada upped their price objective on shares of Clorox from $137.00 to $151.00 in a research note on Wednesday, May 3rd. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Clorox from $147.00 to $149.00 in a research note on Tuesday, April 18th. UBS Group increased their price target on shares of Clorox from $148.00 to $162.00 in a research note on Wednesday, May 3rd. Finally, Barclays increased their price target on shares of Clorox from $118.00 to $124.00 in a research note on Sunday, May 14th. Seven investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus target price of $148.54.
Clorox Price Performance
Clorox (NYSE:CLX – Get Rating) last released its earnings results on Tuesday, May 2nd. The company reported $1.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.29. The company had revenue of $1.92 billion for the quarter, compared to analyst estimates of $1.82 billion. Clorox had a net margin of 1.03% and a return on equity of 114.67%. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.31 EPS. On average, research analysts expect that The Clorox Company will post 4.55 EPS for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Get a free research report on Clorox from StockNews.com
- Is Diablo IV Causing a Resurgence in Activision Blizzard Stock?
- Sleep-At-Night Stock Sherwin-Williams Is Ready To Rebound
- MongoDB: An AI Play That’s About To Boil Over
- Will China’s $72 Billion EV Tax Breaks Help NIO Stock Recover?
- Five stocks we like better than Clorox
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.